This page follows insider dealings at Atomo Diagnostics Limited as filed with ASX. 2 insiders have disclosed 2 filings since 18 October 2025.
The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
Over the last twelve months, not one insider purchase of Atomo Diagnostics Limited stock was filed.
Across the 2,222 companies tracked on its exchange, the median is 3 filings; at 2 filings, this issuer sits below that mark.
These figures are compiled from regulatory filings published by ASX. They describe what insiders did and are not a recommendation.
Transparent value + quality ranking, distinct from the insider signal.
FY ended June 2026 · cache
2 of 2 declarations
Atomo Diagnostics Limited is a company focused on the development of medical diagnostic devices. It is listed on the XASX.